Trofosfamide
![]() | |
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
N,N,3-tris(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amide 2-oxide | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Identifiers | |
| CAS Number |
22089-22-1 |
| ATC code | L01AA07 |
| PubChem | CID 65702 |
| UNII |
H64JRU6GJ0 |
| KEGG |
D07252 |
| ChEMBL |
CHEMBL462019 |
| Chemical data | |
| Formula | C9H18Cl3N2O2P |
| Molar mass | 323.58 g/mol |
| |
| | |
Trofosfamide (INN) is a nitrogen mustard alkylating agent.
It is sometimes abbreviated "TRO".[1]
References
- ↑ Jahnke K, Thiel E, Bechrakis NE, et al. (December 2008). "Ifosfamide or trofosfamide in patients with intraocular lymphoma". J. Neurooncol. 93 (2): 213–7. doi:10.1007/s11060-008-9761-8. PMID 19099202.
| ||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Wednesday, September 02, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.

